Search results for " Progression"

showing 10 items of 1092 documents

SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS

2019

Copyright © 2019 Pinto and de Carvalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

medicine.medical_specialtyVital capacityPrognostic variableamyotrophic lateral sclerosisNeurologyNeurologipredictorlcsh:RC346-429functional outcome03 medical and health sciencesFEV1/FVC ratioslow vital capacity0302 clinical medicineInternal medicinemedicineRespiratory function030212 general & internal medicineAmyotrophic lateral sclerosisRespiratory systemlcsh:Neurology. Diseases of the nervous systembusiness.industryProportional hazards modelNeurosciencesBrief Research Reportmedicine.diseaseNeurologyCardiologyrate of progressionNeurology (clinical)business030217 neurology & neurosurgeryNeurovetenskaperFrontiers in Neurology
researchProduct

Disease Progression in COPD Patients Classified as Gold D According to Gold 2011 or Gold 2017 in the Real-Life Daccord Study

2019

medicine.medical_specialtybusiness.industryCopd patientsInternal medicineDisease progressionMedicinebusinessC102. COPD: RISK PREDICTION AND PROGNOSIS
researchProduct

Progressively fading asymptomatic brownish macules

2010

medicine.medical_specialtybusiness.industryDermatologyDermatologyAsymptomaticHyperpigmentationDisease ProgressionmedicineHumansFemaleFadingmedicine.symptomChildbusinessFollow-Up StudiesClinical and Experimental Dermatology
researchProduct

Clinical Presentation and Complications of Achalasia

2001

Patients with achalasia often present with atypical symptoms. If these occur in the context of "normal" morphological findings, the diagnosis may be delayed for several years. However, a careful interview and the use of modern methods that concentrate on pathophysiologic aspects always allow an early diagnosis and the initiation of therapy that affects most but rarely all symptoms. Finally, regardless of whether this therapy remains partially or totally effective, patients require some follow-up since serious and late complications may occur.

medicine.medical_specialtybusiness.industryDisease progressionGastroenterologyHeartburnAchalasiaContext (language use)Chest painmedicine.diseaseEsophageal myotomySeverity of illnessmedicinemedicine.symptomIntensive care medicinebusinessGastrointestinal Endoscopy Clinics of North America
researchProduct

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Mul…

2019

Continuous treatment with lenalidomide (R) and dexamethasone (d) is a standard of care for multiple myeloma (MM) patients (pts) not candidates for autologous stem cell transplantation (ASCT). As previously reported, the addition of Clarithromycin (C) to Rd has proven to be safe and effective, and case-control analyses suggested a significant additive value with the combination. C optimizes the therapeutic effect of glucocorticoids by increasing the area under the curve, has immunomodulatory effects and may have direct antineoplastic properties. However, there are not randomized phase III trials confirming these results. GEM-Claridex in an open, randomized, phase III trial for untreated new…

medicine.medical_specialtybusiness.industryImmunologyDisease progressionCell BiologyHematologymedicine.diseaseBiochemistrylaw.inventionTransplantationClinical trialAutologous stem-cell transplantationRandomized controlled triallawInternal medicinemedicineIn patientbusinessMultiple myelomaLenalidomidemedicine.drugBlood
researchProduct

Atteinte de la Muscularis Mucosae dans les tumeurs urothéliales T1 de vessie : facteur pronostique de progression après immunothérapie par BCG

2012

OBJECTIVES: To study the prognostic impact of muscularis mucosae (MM) invasion for pT1 bladder cancer treated by transurethral resection (TUR) and adjuvant Bacille Calmette-Guerin (BCG) intravesical immunotherapy. METHODS: Sixty-six patients treated by BCG intravesical instillations were substaged into pT1a and pT1b, regarding Muscularis Mucosae invasion. Tumor grade, associated carcinoma in situ (CIS), multifocality, tumoral size up to 3cm, BCG maintenance were noted. With a mean follow-up of 50.5±38 months, we studied recurrence, progression, overall and specific survival. Cox's model method was used for multivariate analysis. RESULTS: Tumor recurrence was observed in 30±7% and 43±10% (P=…

medicine.medical_specialtyeducation.field_of_studyPathologyMuscularis mucosaeBladder cancerbusiness.industryUrologymedicine.medical_treatmentCarcinoma in situPopulation030232 urology & nephrologyImmunotherapymedicine.diseaseGastroenterology3. Good healthCystectomy03 medical and health sciences0302 clinical medicineTumor progression030220 oncology & carcinogenesisInternal medicinemedicineProgression-free survivaleducationbusinessProgrès en Urologie
researchProduct

American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Rev…

2015

Polycystic Ovary Syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the Androgen Excess and PCOS Society (AES) aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. It is a summary of current best practices in 2015. PCOS has been defined using various criteria, including menstrual irregularity, hyperandrogenism, and polycystic ovary morphology (PCOM). General agreement exists among specialty society guidelines that the diagnosis of PCOS must be based on the presence o…

medicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismType 2 diabetesAndrogen ExcessSeverity of Illness IndexLipoprotein particleFlutamideAnovulationImpaired glucose tolerancechemistry.chemical_compoundEndocrinologyInsulin resistancePregnancyInternal medicinemedicineHumansLife StylehirsutismMetabolic Syndromebusiness.industryHyperandrogenismnutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryPolycystic ovarian diseaseGestational diabetesEndocrinologyDiabetes Mellitus Type 2chemistryDisease ProgressionSpironolactoneFemaleInsulin ResistanceMetabolic syndromeHyperandrogenismbusinessInfertility FemaleAlgorithmsPolycystic Ovary SyndromeEndocrine Practice
researchProduct

Langzeitverlauf und angiographische Befunde bei serpiginöser Choroiditis

2006

Background: Long-term follow-up and angiographic findings of serpiginous choroiditis, a chronic disease with recurrences of unknown origin, are reported. Patients and Methods: A retrospective analysis of the data of 4 patients with serpiginous choroidopathy, who were treated in the eye clinic of Mainz in the past 10-18 years was made. Progression of disease was documented by photography, as well as fluorescein and indocyanine green angiography. Patients with acute lesions were treated with steroids per os for some weeks. Results: All 8 eyes developed 2 - 7 recurrences with progression of the chorioretinal scars. In cases of macular involvement the functional results were worse. No choroidal…

medicine.medical_specialtymedicine.diagnostic_testSerpiginous choroiditisbusiness.industryIndocyanine green angiographyFluorescein angiographymedicine.diseaseeye diseasesOphthalmologychemistry.chemical_compoundChronic diseasechemistryOphthalmologyRetrospective analysisMedicinesense organsFluoresceinbusinessMacular involvementClinical progressionKlinische Monatsblätter für Augenheilkunde
researchProduct

Transdermal estrogens do not appear to modify the extent of lesional areas of aortic atherosclerosis in oophorectomized rabbits on a cholesterol-rich…

2000

Cardiovascular disease (CVD) is the leading cause of death in older women in industrialised countries. It has been suggested that it is the cessation of estrogen production by the ovaries that puts postmenopausal women at increased risk of CVD. Estrogen therapy has demonstrated a protective effect against CVD and several reports suggest that diverse mechanisms may be involved. Oral estrogen appears to be associated with a better lipid profile than the use of transdermal estrogens; however, it is assumed that estrogens, oral and non-oral, have direct actions on the blood vessels that may exert an important role in cardiovascular disease prevention. To investigate the effect of transdermal es…

medicine.medical_specialtymedicine.drug_classArteriosclerosisOvariectomyAortic DiseasesPlaceboAdministration CutaneousCholesterol Dietarychemistry.chemical_compoundTransdermal estrogenInternal medicinemedicineAnimalsTreatment FailureTransdermalmedicine.diagnostic_testEstradiolVascular diseaseCholesterolbusiness.industrymedicine.diseaseEndocrinologychemistryEstrogenDisease ProgressionFemaleTroloxRabbitsCardiology and Cardiovascular MedicineLipid profilebusinessAtherosclerosis
researchProduct

Unusual giant chromophobe renal cancer totally managed with laparoscopic technique: Report of a case

2020

Highlights • We describe a case report of giant renal cell chromophobe carcinoma totally treated by laparoscopic surgery. • The size of renal lesion represents a critical point in surgical approach because to perform a laparoscopic radical nephrectomy can be challenging even for skilled surgeons in giant renal tumors. • A brief review of literature was performed to identify outcomes and potentially surgical advantages of laparoscopic approach for retroperitoenal liposarcoma. • The possibility of the laparoscopic approach derives from from the preoperative identification of adipose cleavage, from the absence of invasion of major vascular axes, from the absence of distant metastatic lesions.

medicine.medical_specialtymedicine.medical_treatmentChromophobe Renal Cell CarcinomaCase ReportChromophobe cellLesion03 medical and health sciences0302 clinical medicinemedicineAtypiaGiant renal massKidneybiologybusiness.industryCD117medicine.diseaseNephrectomyLaparoscopic nephrectomyChromophobe carcinomamedicine.anatomical_structureTumor progression030220 oncology & carcinogenesisbiology.proteinLaparoscopy030211 gastroenterology & hepatologySurgeryRadiologymedicine.symptombusinessInternational Journal of Surgery Case Reports
researchProduct